Buys
Open market- Shares
- +4,184
- Avg price
- $24.09
- Total value
- +$100,793
J. Russel Denton - Senior Vice President, General Counsel, and Secretary at Caris Life Sciences, Inc.
Issuer-level insider activity
- Role
- Senior Vice President, General Counsel, and Secretary
- Issuer ticker
- CAI on Nasdaq
- Entity type
- Individual
- Source filing history
- Open source filing history
Identity
Names, identifiers, and filing context for this profile.
1 identity field
Source evidence
Original filing metadata and source links for verification.
1 source field
Past-year transaction volume for J. Russel Denton in Caris Life Sciences, Inc.
Sells
Open market- Shares
- Avg price
- Total value
Net
Past year- Shares
- +4,184
- Share %
- 100%
- Total value
- +$100,793
Reported holdings for J. Russel Denton in Caris Life Sciences, Inc.
Form 4 holding
Senior Vice President, General Counsel, and Secretary
Caris Life Sciences, Inc.
- Security class
- Common Stock
- Shares / value
- 181,515
- Estimated value
- $3,245,488
- Report date
- 15 May 2026
- Price
- $17.88
- Ownership
- Direct
Form 4 holding
Senior Vice President, General Counsel, and Secretary
Caris Life Sciences, Inc.
- Security class
- Common Stock
- Shares / value
- 9,184
- Estimated value
- $164,209
- Report date
- 15 May 2026
- Price
- $17.88
- Ownership
- By Trust
Form 4 holding
Senior Vice President, General Counsel, and Secretary
Caris Life Sciences, Inc.
- Security class
- Stock Option
- Shares / value
- 255,000
- Estimated value
- Report date
- 03 Mar 2025
- Price
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
Transaction history for J. Russel Denton in Caris Life Sciences, Inc.
| Sym | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares after | Date | Ownership |
|---|
* marks a reported price that did not pass the local price check.